Very Early Diagnosis of Systemic Sclerosis: Deciphering the heterogeneity of systemic sclerosis in the very early stages of the disease-Reference-Cited by-同舟云学术

Very Early Diagnosis of Systemic Sclerosis: Deciphering the heterogeneity of systemic sclerosis in the very early stages of the disease

Published:2022-10-11 Issue:1 Volume:8 Page:3-6
ISSN:2397-1983
Container-title:Journal of Scleroderma and Related Disorders
language:en
Short-container-title:Journal of Scleroderma and Related Disorders

Author:

Lescoat Alain¹²^ORCID

Affiliation:

1. Department of Internal Medicine and Clinical Immunology, CHU Rennes, University of Rennes 1, Rennes, France

2. CHU Rennes, Inserm, EHESP, Institut de Recherche en Santé, Environnement et Travail UMR_S 1085, Rennes, France

Abstract

The early diagnosis of systemic sclerosis has been a major challenge for the scleroderma community in the past 50 years. The recent publication of the predictive value of the VEDOSS (Very Early Diagnosis of Systemic Sclerosis) criteria in the Lancet Rheumatology in December 2021 has provided an unprecedented insight in the early stages of the disease. This editorial discusses the main findings from this 2021 VEDOSS publication and highlights key unanswered questions to be proposed on the research agenda in very early systemic sclerosis.

Publisher

SAGE Publications

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://journals.sagepub.com/doi/pdf/10.1177/23971983221129211

Reference29 articles.

1. The nosology of systemic sclerosis: how lessons from the past offer new challenges in reframing an idiopathic rheumatological disorder

2. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

3. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

4. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

5. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis;Molecular Aspects of Medicine;2024-04

2. What comes before scleroderma?;Systemic Sclerosis - Recent Advances and New Perspectives;2024-03-27

3. Sleep quality and clinical-laboratory variables associated with sleep disturbances in patients with systemic sclerosis;Polish Archives of Internal Medicine;2024-02-05

4. Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine;The Lancet Rheumatology;2023-11

5. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma;JAMA Dermatology;2023-08-01